characteristics.text: SAMN42652248
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-19T16:06:18.550Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-09-24T08:15:13.930Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS22071394
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS22071394
characteristics.characteristic: SRA accession
characteristics.text: RNA
characteristics.characteristic: analyte type
characteristics.text: NCI_BotensilimabEfficacy
characteristics.characteristic: biospecimen repository
characteristics.text: sam-7728_T1
characteristics.characteristic: biospecimen repository sample id
characteristics.text: Abdominal Wall Mass
characteristics.characteristic: body site
characteristics.text: phs003704
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: GRU-NPU
characteristics.characteristic: gap_consent_short_name
characteristics.text: 6236154
characteristics.characteristic: gap_sample_id
characteristics.text: 4966776
characteristics.characteristic: gap_subject_id
characteristics.text: Yes
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Clinical Trial
characteristics.characteristic: study design
characteristics.text: Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy
characteristics.characteristic: study name
characteristics.text: sam-7728_T1
characteristics.characteristic: submitted sample id
characteristics.text: sam-7728
characteristics.characteristic: submitted subject id
characteristics.text: NCI_BotensilimabEfficacy
characteristics.characteristic: submitter handle
characteristics.text: Tumor RNA sample from Abdominal Wall Mass of a human participant in the dbGaP study "Botensilimab, an Fc-enhanced Anti-CTLA-4 Antibody, is Effective Against Tumors Poorly Responsive to Conventional Immunotherapy"
characteristics.characteristic: title